Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
CANNABIS POLAND Aktie jetzt für 0€ handeln |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MPH HEALTH CARE | 18,450 | -2,89 % | HV-Kalender: Aktionärs-Versammlungen u.a. bei centrotherm, CropEnergies, Defama, Encavis, MPH, Rubean, Südzucker, YOC | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
HIGH TIDE | 2,140 | +1,18 % | High Tide schließt mit Cronos Group Inc. eine Vereinbarung über Wandelschuldverschreibungen im Wert von 30 Millionen $ ab | CALGARY, AB, und TORONTO, ON, 16. Juli 2025 / IRW-Press / High Tide Inc. ("High Tide" oder das "Unternehmen") (Nasdaq: HITI) (TSXV: HITI) (FWB: 2LYA), das
erfolgreiche, auf den Einzelhandel fokussierte... ► Artikel lesen | |
COMPASS PATHWAYS | 3,700 | 0,00 % | Compass Pathfinder Limited: Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression | A single administration of COMP360 demonstrated a highly statistically significant and clinically meaningful reduction in symptom severity as measured by MADRS1 with a mean difference of -3.6... ► Artikel lesen | |
PHARMASGP | 28,200 | -0,70 % | EQS-News: PharmaSGP Holding SE: Annahmefrist für das öffentliche Delisting-Erwerbsangebot der FUTRUE GmbH läuft | EQS-News: PharmaSGP Holding SE
/ Schlagwort(e): Delisting
PharmaSGP Holding SE: Annahmefrist für das öffentliche Delisting-Erwerbsangebot der FUTRUE GmbH läuft
18.07.2025... ► Artikel lesen | |
SHANGHAI FOSUN PHARMACEUTICAL | 1,933 | -2,67 % | FOSUN PHARMA (02196): CONNECTED TRANSACTION - CAPITAL REDUCTION OF SUZHOU ANGEL FUND | ||
SEELOS THERAPEUTICS | 0,123 | -8,88 % | Delisting of Securities of Patria Latin American Opportunity Acquisition Corp.; Trevena, Inc.; Seelos Therapeutics, Inc.; DP Cap Acquisition Corp I; Chain Bridge I; Qomolangma Acquisition Corp.; Gaucho Group Holdings, Inc. ... | NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the Class A Ordinary Shares, unit, and warrant of Patria Latin American Opportunity Acquisition... ► Artikel lesen | |
PROMINO NUTRITIONAL SCIENCES | 0,034 | -100,00 % | Promino Nutritional Sciences, Inc.: Promino Nutritional Sciences Inc. Comments on Trading Halt | Burlington, Ontario--(Newsfile Corp. - May 20, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the "Company" or "Promino") provides an update on the trading halt... ► Artikel lesen | |
SAVARA | 1,990 | +2,05 % | Savara Inc.: Savara Announces Encore Presentations From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at Two Upcoming Scientific Conferences | Savara Inc. (Nasdaq: SVRA) (the Company), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, announced encore presentations of top-line data from the pivotal, Phase... ► Artikel lesen | |
EVOLUS | 7,700 | -2,53 % | Evolus Expands Global Footprint with Introduction of Nuceiva (botulinum toxin type A) in France | Launching into this key growth market1 as part of the company's geographic expansion strategy Evolus to provide Nuceiva to French medical aesthetics healthcare professionals through its... ► Artikel lesen | |
ATYR PHARMA | 5,200 | +0,97 % | aTyr Pharma, Inc.: aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | SAN DIEGO, May 16, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) ("aTyr" or "the Company"), a clinical stage biotechnology company engaged in the discovery and development of first-in-class... ► Artikel lesen | |
EVOKE PHARMA | 3,840 | -100,00 % | Evoke Pharma, Inc.: Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036 | SOLANA BEACH, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with... ► Artikel lesen | |
CIPHER PHARMACEUTICALS | 7,900 | -2,47 % | Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders | ||
IMMUNOPRECISE ANTIBODIES | 1,480 | 0,00 % | ImmunoPrecise Antibodies Ltd. - 6-K, Report of foreign issuer | ||
STEVANATO GROUP | 21,800 | +1,87 % | Stevanato Group S.p.A.: Stevanato Group to Participate in Upcoming Investor Conferences | Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today... ► Artikel lesen | |
NIPPON KAYAKU | 7,600 | 0,00 % | Dividendenbekanntmachungen (28.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC ADR US00108N1000 0,3716 USD 0,3442 EUR ACOM CO LTD JP3108600002 7 JPY 0,0429 EUR ADVANEX INC JP3213400009 20... ► Artikel lesen |